PFC
AGIO icon

Phocas Financial Corp’s Agios Pharmaceuticals AGIO Stock Holding History

Phocas Financial Corp’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,608
Closed -$1.87M – 149
2025
Q3 		$1.87M Buy
+46,608
New +$1.75M 0.24% 113
2021
Q4 		– Sell
-61,076
Closed -$2.82M – 195
2021
Q3 		$2.82M Buy
61,076
+31,018
+103% +$1.5M 0.36% 110
2021
Q2 		$1.66M Buy
+30,058
New +$1.68M 0.21% 128

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Phocas Financial Corp's AGIO Position: Q4 2025 in Review

Phocas Financial Corp sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 46,608 shares — an estimated $1.87M sold.

Phocas Financial Corp first reported a position in AGIO in Q2 2021 and held it in 3 quarters. The position peaked at $2.82M in Q3 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Phocas Financial Corp reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Phocas Financial Corp sold 46,608 Agios Pharmaceuticals shares in Q4 2025, an estimated $1.87M.
  • Phocas Financial Corp first reported a position in Agios Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Phocas Financial Corp's Agios Pharmaceuticals position peaked at $2.82M in Q3 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Phocas Financial Corp's 13F filing for Q4 2025, filed 21 Jan 2026.